One possible explanation is that TIC10‐induced TRAIL activates the noncanonical NFκB2 pathway in cancer cells, leading to the production of cytokines such as IL‐6, IL‐10, and GM‐CSF [38]. The gene discussed is IL10; the disease is cancer.